Trump administration to restrict COVID vaccines to seniors and high-risk groups, pending more data for everyone else.

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.

The vaccine eligibility change is a threat to the health of Americans, some experts say, adding that the FDA is not being ...

The FDA plans to limit access to certain high-risk groups and also told Pfizer and Moderna to update their warning labels ...

On May 20, U.S. Food and Drug Administration (FDA) officials announced that Covid-19 vaccines will no longer be available to ...

Healthy and under the age of 65? You might not need to receive an annual COVID-19 booster. What to know about new guidelines.

Top officials with the U.S. Food and Drug Administration are changing the agency's standards for updated COVID-19 booster ...

The Food and Drug Administration (FDA) will require more evidence for what top officials describe as the uniquely American ...

Regulators will require more data showing the shots are safe and effective for healthy adults and children, by requiring ...

Previously, updated COVID vaccines had been recommended annually by the CDC for everyone over the age of 6 months. The CDC has historically set vaccine recommendations, while the FDA determines which ...

Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...